David G Mc Kenna

Title: The Innovations of David G Mc Kenna

Introduction

David G Mc Kenna is a notable inventor based in McHenry, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of variants of the human α7 nicotinic acetylcholine receptor. With a total of 2 patents, his work has implications for both scientific research and potential therapeutic applications.

Latest Patents

David's latest patents include a variant human α7 acetylcholine receptor subunit, which features an amino acid substitution at the valine-274 position of the wild-type human α7 nAChR. This innovation provides nucleic acid molecules encoding the variant human α7 nAChR, as well as vectors and host cells containing such nucleic acid molecules. Additionally, the patents outline methods for producing the variant and using it for screening compounds for activity at the nAChR.

Career Highlights

David G Mc Kenna is currently employed at Abbott Laboratories Corporation, where he continues to advance his research in the field of nicotinic acetylcholine receptors. His work is pivotal in understanding the mechanisms of these receptors and their potential applications in medicine.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Clark A Briggs and Murali Gopalakrishnan. These collaborations have enriched his research and contributed to the successful development of his patented innovations.

Conclusion

David G Mc Kenna's contributions to the field of biochemistry through his patents on the human α7 nicotinic acetylcholine receptor highlight his innovative spirit and dedication to scientific advancement. His work not only enhances our understanding of receptor biology but also opens new avenues for therapeutic exploration.